| scholarly article | Q13442814 |
| P2093 | author name string | Bin Li | |
| Yao Zhang | |||
| Chunfang Zhang | |||
| Chaojun Duan | |||
| Jinchun Wu | |||
| Yanhua Mou | |||
| Busheng Hu | |||
| P2860 | cites work | Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal | Q23923870 |
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| NCBI GEO: archive for functional genomics data sets--update | Q24595691 | ||
| The PI3K/AKT Pathway and Renal Cell Carcinoma | Q26800216 | ||
| Ferroptosis, a new form of cell death, and its relationships with tumourous diseases | Q28076336 | ||
| GOplot: an R package for visually combining expression data with functional analysis. | Q30949780 | ||
| TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data | Q31034005 | ||
| Web-TCGA: an online platform for integrated analysis of molecular cancer data sets | Q31043453 | ||
| The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data | Q33592056 | ||
| Iron and cancer: more ore to be mined | Q33677592 | ||
| Identification of miR‑124a as a novel diagnostic and prognostic biomarker in non‑small cell lung cancer for chemotherapy | Q33828158 | ||
| The genetic basis of kidney cancer: a metabolic disease | Q34087148 | ||
| Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation | Q35848419 | ||
| Rap1GAP regulates renal cell carcinoma invasion | Q35871610 | ||
| Network analysis of psoriasis reveals biological pathways and roles for coding and long non-coding RNAs. | Q36177423 | ||
| Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma | Q36530958 | ||
| Iron and cancer: recent insights | Q36909297 | ||
| Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells | Q38767064 | ||
| Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma | Q38785857 | ||
| Iron and ferroptosis: A still ill-defined liaison | Q39169905 | ||
| Overview of iron metabolism in health and disease | Q39179833 | ||
| The null hypothesis of GSEA, and a novel statistical model for competitive gene set analysis | Q40223125 | ||
| Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. | Q46231620 | ||
| Association of functional polymorphisms of SLC11A1 with risk of esophageal cancer in the South African Colored population | Q46717865 | ||
| Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients | Q47109274 | ||
| Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy | Q49163340 | ||
| Elevated transgelin/TNS1 expression is a potential biomarker in human colorectal cancer | Q49191381 | ||
| CYP4X1 inhibition by flavonoid CH625 normalizes glioma vasculature through reprogramming TAMs via CB2 and EGFR-STAT3 axis | Q50043468 | ||
| Overexpression of Functional SLC6A3 in Clear Cell Renal Cell Carcinoma. | Q51468533 | ||
| Changes in metabolic profile, iron and ferritin levels during the treatment of metastatic renal cancer - A new potential biomarker? | Q51576589 | ||
| GSEA-P: a desktop application for Gene Set Enrichment Analysis. | Q51909999 | ||
| Genetic variants in XDH are associated with prognosis for gastric cancer in a Chinese population. | Q52650072 | ||
| Candidate genes in gastric cancer identified by constructing a weighted gene co-expression network. | Q55346557 | ||
| Survival outcomes for advanced kidney cancer patients in the era of targeted therapies. | Q55446451 | ||
| Identification of differentially expressed genes in cervical cancer by bioinformatics analysis | Q57173326 | ||
| Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women | Q57610327 | ||
| The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma | Q57903458 | ||
| ALDH1L1 and ALDH1L2 Folate Regulatory Enzymes in Cancer | Q58577785 | ||
| Ferroptosis, a new form of cell death: opportunities and challenges in cancer | Q64103562 | ||
| Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma. | Q64921061 | ||
| Yeast extract inhibits the proliferation of renal cell carcinoma cells via regulation of iron metabolism. | Q66795252 | ||
| Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma | Q85071943 | ||
| Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation | Q90558473 | ||
| Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma | Q90709698 | ||
| Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma | Q91626168 | ||
| A comparison of the prognosis of papillary and clear cell renal cell carcinoma: Evidence from a meta-analysis | Q91655675 | ||
| Uncovering biomarker genes with enriched classification potential from Hallmark gene sets | Q91666386 | ||
| The Diagnostic Value of Arginase-1, FTCD, and MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and in Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver | Q91733861 | ||
| Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression | Q91833664 | ||
| MiR-218 suppresses metastasis and invasion of endometrial cancer via negatively regulating ADD2 | Q92164804 | ||
| Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy | Q92966885 | ||
| Iron metabolism and its contribution to cancer (Review) | Q92989994 | ||
| Pan-cancer analysis of iron metabolic landscape across the Cancer Genome Atlas | Q93034368 | ||
| The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma | Q93101031 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ggplot2 | Q326489 |
| WGCNA | Q102537983 | ||
| limma | Q112236343 | ||
| P304 | page(s) | 788 | |
| P577 | publication date | 2020-05-22 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma | |
| P478 | volume | 10 |
Search more.